Beginning in January, physicians will have the new option of a liquid long-acting methylphenidate treatment that requires only once-daily dosing. The medication, made by NextWave Pharmaceuticals (which will be sold to Pfizer), is called Quillivant XR and will be available at a 25mg/5ml (5mg/ml) concentration. The recommended starting dose for children 6 years old and […]
Tags: adhd, liquid methylphenidate, Quillivant